Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It offer tests for disorders in cardiovascular, hereditary cancer, neurology, pediatrics, and other rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Current Report (Form 8-K | Period ending 2024-02-13)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Invitae Corp (NVTA US)

Current Report (Form 8-K | Period ending 2024-02-13)

Current Report (Form 8-K | Period ending 2024-02-06)

US SEC Form 8-K/A for Invitae Corp

Current report pursuant to Section 13 or 15(d) (PDF)

Current report pursuant to Section 13 or 15(d) (PDF)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)